Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining ...

A new HIV protection jab has been approved for roll out across Northern Ireland. The CAB-LA injection will be provided every ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year. The ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, ...

UNAIDS officials in Pakistan say they are working with local pharmaceutical manufacturers to explore the possibility of ...

The President Bola Ahmed Tinubu-led federal government has shared details after receiving the HIV prevention injection known as Lenacapavir into the country.

The Federal Government has confirmed the arrival of the long-acting HIV prevention injection, Lenacapavir, marking a major ...

The Global Fund has committed an additional Sh256 million ($2 million) to support Kenya’s rollout of the long-acting HIV ...